XML 90 R79.htm IDEA: XBRL DOCUMENT v3.24.2.u1
INCOME/LOSS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Numerator:        
Net loss attributable to Acacia Research Corporation $ (8,446) $ (18,779) $ (8,632) $ (9,332)
Dividend on Series A redeemable convertible preferred stock 0 (700) 0 (1,400)
Accretion of Series A redeemable convertible preferred stock 0 (1,676) 0 (3,230)
Net loss attributable to common stockholders - Basic (8,446) (21,155) (8,632) (13,962)
Net loss attributable to common stockholders - Diluted $ (8,446) $ (21,155) $ (8,632) $ (13,962)
Denominator:        
Weighted average number of shares outstanding - Basic 100,079,803 58,408,711 99,912,854 53,219,152
Weighted average number of shares outstanding, diluted 100,079,803 58,408,711 99,912,854 53,219,152
Basic net income (loss) per common share (in usd per share) $ (0.08) $ (0.36) $ (0.09) $ (0.26)
Diluted net (loss) income per common share (in usd per share) $ (0.08) $ (0.36) $ (0.09) $ (0.26)
Anti-dilutive potential common shares excluded from the computation of diluted net income/loss per share:        
Antidilutive securities excluded from computation of earnings per share (in shares) 3,898,180 36,265,921 3,898,180 36,265,921
Equity-based incentive awards        
Anti-dilutive potential common shares excluded from the computation of diluted net income/loss per share:        
Antidilutive securities excluded from computation of earnings per share (in shares) 3,898,180 4,759,072 3,898,180 4,759,072
Series B warrants        
Anti-dilutive potential common shares excluded from the computation of diluted net income/loss per share:        
Antidilutive securities excluded from computation of earnings per share (in shares) 0 31,506,849 0 31,506,849